Market Overview

Abbott Declares $0.14/Share Qtr. Dividend, Says Spinoff AbbVie Intends Recommending $0.40/Share Dividend

Share:
Related ABT
Benzinga's M&A Chatter for Thursday August 27, 2015
Benzinga's Volume Movers
ESC - Abbott Absorbs More Good News For Dissolving Stent (Seeking Alpha)

The board of directors of Abbott (NYSE: ABT) today declared its 356^th consecutive quarterly cash dividend. The quarterly dividend is $0.14 per share, payable Feb. 15, 2013, to shareholders of record on Jan. 15, 2013. The management of AbbVie, Abbott's research-based pharmaceuticals business, intends to recommend a cash dividend, subject to AbbVie board approval, of $0.40 per share, which together with Abbott's dividend will equal a cash dividend of $0.54 per share, an increase of nearly 6 percent over Abbott's quarterly cash dividend declared in September 2012.

Abbott's annualized cash dividend of $0.56 per share, combined with AbbVie's annualized cash dividend of $1.60 per share equals a total annualized cash dividend of $2.16 per share, compared to the annualized cash dividend of Abbott, prior to separation, of $2.04 per share. Future quarterly dividends, including the expected AbbVie dividend in February 2013, are subject to approval by each company's board of directors.

Posted-In: News Dividends

 

Related Articles (ABT)

View Comments and Join the Discussion!

Get Benzinga's Newsletters